Harvard Apparatus Regenerative Technology, Inc. Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price
Harvard Apparatus Regenerative Technology, Inc. (HRGN) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price of $7.59 per share for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice · last filed 2023-03-30
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2022 was $7.59, a 78.44% decline from fiscal 2021.
- Harvard Apparatus Regenerative Technology, Inc. share-based compensation arrangements by share-based payment award, options, expirations in period, weighted average exercise price for fiscal 2021 was $35.20.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price 12 month |
|---|---|---|
| 2022-12-31 | $7.59 10-K · filed 2023-03-30 | |
| 2022-09-30 | $7.59 10-Q · filed 2022-11-14 | |
| 2021-12-31 | $35.20 10-K · filed 2022-03-31 |